Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Dan Turner on vedolizumab in children with IBD

    Dan Turner on vedolizumab in children with IBD

    FromThe Lancet Gastroenterology & Hepatology in conversation with

    Start listeningView podcast show

    Dan Turner on vedolizumab in children with IBD

    FromThe Lancet Gastroenterology & Hepatology in conversation with

    ratings:
    Length:
    15 minutes
    Released:
    Jan 6, 2023
    Format:
    Podcast episode

    Description

    Dan Turner (Shaare Zedek Medical Center) discusses the VEDOKIDS study on the safety, effectiveness, and dosing of vedolizumab in children with IBD.Read the full article:Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS)
    Released:
    Jan 6, 2023
    Format:
    Podcast episode

    Titles in the series (74)

    Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.